The databases indicated that, despite the aforementioned, patients with ER-positive breast cancer had greater levels of FLRT2 gene expression, and it was positively correlated with ESR2 gene expression in Basal and Luminal A breast cancer patients. Here, ESR2 is linked to breast cancer.